Ausgabe 2/2005
Inhalt (11 Artikel)
Taurine May Prevent Diabetic Rats from Developing Cardiomyopathy also by Downregulating Angiotensin II Type2 Receptor Expression
Changyun Li, Linsheng Cao, Qiutang Zeng, Xiaoqing Liu, Yanzhou Zhang, Tianran Dai, Dongnan Hu, Kai Huang, Yong Wang, Xiang Wang, Dazhu Li, Zhijian Chen, Jiaming Zhang, Yushu Li, Ranjit Sharma
Counteracting Effects of High Density Lipoprotein-Cholesterol Subfractions on Statin-Induced Growth Arrest
Masahiro Fujino, Shin-ichiro Miura, Hiroyuki Tanigawa, Yoshino Matsuo, Keijiro Saku
Acute Administration of Angiotensin Converting Enzyme Inhibitors in Thrombolysed Myocardial Infarction Patients Is Associated with a Decreased Incidence of Heart Failure, but an Increased Re-Infarction Risk
Adriaan A. Voors, Pieter J. de Kam, Maarten P. van den Berg, Claudio Borghi, Judith S. Hochman, Dirk J. van Veldhuisen, Wiek H. van Gilst
Impact of a Standardized Titration Protocol with Carvedilol in Heart Failure: Safety, Tolerability, and Efficacy—A Report from the GESICA Registry
Daniel Nul, Carola Zambrano, Alejandro Diaz, Daniel Ferrante, Sergio Varini, Saúl Soifer, Hugo Grancelli
Beyond the Statins: New Therapeutic Perspectives in Cardiovascular Disease Prevention
M. John Chapman
Comparison of Impedance Cardiography and Thermodilution-Derived Measurements of Stroke Volume and Cardiac Output at Rest and During Exercise Testing
A. Scherhag, J. J. Kaden, E. Kentschke, T. Sueselbeck, M. Borggrefe
Ximelagatran Compared with Warfarin for the Prevention of Systemic Embolism and Stroke. An Imputed Placebo Analysis
Colin Berry, John Norrie, John J. V. McMurray
Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy
Christoph Hanefeld, Nadine Bulut-Streich, Daniel Bulut, Claudia Graf, Andreas Mügge, Martin Spiecker
Intracranial Bleeding Associated with Clopidogrel
Serkan Cay, Mehmet Birhan Yilmaz, Sule Korkmaz